Euro Vital Pharma GmbH
Euro Vital Pharma (EVP), which is based in Hamburg, is a pharmaceutical company and over the last 25 years has become the market leader in the German OTC Private Label Retail market. EVP develops, manufactures and markets healthcare products including pharmaceuticals, medical devices and nutritional supplements. Thanks to its comprehensive product portfolio and own Marketing Authorizations, EVP can support its customers beyond the supply of products in their strategy and development of an own store-brand offering. Customers include all leading drugstore and grocery retailers.
capiton acquires EVP together with management from Aenova Holding GmbH. Financing of the transaction is provided by capiton’s current investment vehicle, capiton V, management and banks.
Based on its leading market position, capiton is planning to grow the business both organically in Germany and abroad, as well as through targeted acquisitions.
The transaction remains subject to approval from competition authorities. Buyers and sellers have agreed not to disclose the financial terms of the transaction. capiton was advised in this transaction by Roland Berger (commercial), Deloitte (financial), EY (tax), BMH (legal), INTARGIA (IT), AvS (management audit), Willis (insurance), Tauw (ESG) and Fidelio Healthcare Partners (industry expert).